期刊文献+

H2AT120蛋白磷酸化致癌的动力学特性

Kinetics of carcinogenesis caused by phosphorylation of H2AT120 protein
下载PDF
导出
摘要 基于Hill动力学与Michaelis-Menten方程,建立理论模型研究H2AT120组蛋白磷酸化促进癌症发生发展的动力学特性.研究发现,在H2AubK119-H2AT120D-H2AT120P信号通路中,VRK激酶(vaccinia-related kinase 1)在很大程度上调控H2AT120磷酸化的动力学.VRK过高或者过低表达,都会促使H2AT120磷酸化出现异常,导致基因的不恰当表达,致使细胞癌变发生.通过考察体系演化过程中的动力学稳定性,我们发现,H2AubK119、H2AT120D、H2AT120P随时间演化动力学出现Hopf分岔,表明了体系随时间演化动力学的转变特性,由此也表明了,H2AT120蛋白磷酸化促进癌症发生发展的复杂性.基于本文模型,我们解释了VRK、H2AubK119、H2AT120D对致癌的调控特性,进一步理解了H2AubK119-H2AT120D-H2AT120P信号回路的致癌作用机理.理论结果符合实验,揭示了H2AT120磷酸化导致表观遗传变异的一种致癌机理,可为设计阻止由H2AT120发生变异诱发的癌症提供理论依据. In this paper,based on Hill kinetics and Michaelis-Menten equation,we built a theoretical model to study the kinetics of H2 AT120 protein phosphorylation promoting the oncogenic transformation.We found that in H2 AubK119-H2 AT120 D-H2 AT120 P signaling pathway,the vaccinia-related kinase 1(VRK1)regulates the kinetic behavior of H2 AT120 protein phosphorylation.Overexpression or underexpression of VRK will cause abnormalities in the phosphorylation process of H2 AT120,which leads to improper gene expression and oncogenic transformation.By investigating the dynamic stability of the H2 AubK119-H2 AT120 D-H2 AT120 P signaling pathway system,we found that the H2 AubK119,H2 AT120 D,and H2 AT120 P present Hopf bifurcation.It confirms the transition characteristics of the system’s evolutionary dynamics over time.This shows that the phosphorylation of H2 AT120 protein promotes the complexity of cancer occurrence and development.Based on the model in this article,we explained the carcinogenic regulation characteristics of VRK,H2 AT12 ubiquitination and[H2 AT120 D]mutation.The results can be used to further understand the carcinogenic mechanism induced by the H2 AubK119-H2 AT120 D-H2 AT120 P signaling circuit.The theoretical results are consistent with the experiment,revealing a carcinogenic mechanism of epigenetic changes caused by phosphorylation of H2 AT120 protein,which can provide a theoretical basis for the design to prevent cancers induced by histone mutations.
作者 郭阵雨 蒋中英 赵新军 GUO Zhen-Yu;JIANG Zhong-Ying;ZHAO Xin-Jun(Xinjiang Laboratory of Phase Transitions and Microstructures in Condensed Matters,College of Physical Science and Technology,Yili Normal University,Yining 835000,China;Laboratory of Micro-Nano Electro Biosensors and Bionic Devices,Yili Normal University,Yining 835000,China)
出处 《原子与分子物理学报》 CAS 北大核心 2023年第5期11-20,共10页 Journal of Atomic and Molecular Physics
基金 国家自然科学基金(22163011) 伊犁师范大学科研创新团队培育计划(CXZK2021022) 新疆自然科学基金联合基金(2019D01C333)。
关键词 致癌动力学 H2AT120蛋白 磷酸化 Kinetics of carcinogenesis H2AT120 protein Phosphorylation
  • 相关文献

参考文献2

二级参考文献22

  • 1Ugur Gezer,Duran üstek,Ebru E. Y?rüker,Aris Cakiris,Neslihan Abaci,Gloria Leszinski,Nejat Dalay,Stefan Holdenrieder.Characterization of H3K9me3- and H4K20me3-associated circulating nucleosomal DNA by high-throughput sequencing in colorectal cancer[J].Tumor Biology.2013(1)
  • 2Lin Zhu,Jiaxing Yang,Linhong Zhao,Xue Yu,Lingyao Wang,Fei Wang,Yong Cai,Jingji Jin.Expression of hMOF, but not HDAC4, is responsible for the global histoneH4K16 acetylation in gastric carcinoma[J]. International Journal of Oncology . 2015 (6)
  • 3Anika Nagelkerke,Simon JA van Kuijk,John W Martens,Fred CGJ Sweep,Nicoline Hoogerbrugge,Johan Bussink,Paul N Span.Poor prognosis of constitutive γ-H2AX expressing triple-negative breast cancers is associated with telomere length[J]. Biomark. Med. . 2015 (4)
  • 4Shi-Yong Li,Rong Sun,Hong-Xia Wang,Song Shen,Yang Liu,Xiao-Jiao Du,Yan-Hua Zhu,Wang Jun.Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells[J]. Journal of Controlled Release . 2014
  • 5Chiara Vardabasso,Dan Hasson,Kajan Ratnakumar,Chi-Yeh Chung,Luis F. Duarte,Emily Bernstein.Histone variants: emerging players in cancer biology[J]. Cellular and Molecular Life Sciences . 2014 (3)
  • 6Alexandra P. Zorzi,Mark Bernstein,Yvan Samson,Donna A. Wall,Sunil Desai,Darcy Nicksy,Nancy Wainman,Elizabeth Eisenhauer,Sylvain Baruchel.A phase I study of histone deacetylase inhibitor, pracinostat (SB939), in pediatric patients with refractory solid tumors: IND203 a trial of the NCIC IND program/C17 pediatric phase I consortium[J]. Pediatr Blood Cancer . 2013 (11)
  • 7Gonç,alo Castelo-Branco.The epigenetics of cancer: from non-coding RNAs to chromatin and beyond[J]. Briefings in Functional Genomics . 2013 (3)
  • 8Yukun Zhang,Qian Li,Hong Chen.DNA methylation and histone modifications of Wnt genes by genistein during colon cancer development[J]. Carcinogenesis . 2013 (8)
  • 9Xiaohui Chen,Ning Song,Keitaro Matsumoto,Atsushi Nanashima,Takeshi Nagayasu,Tomayoshi Hayashi,Mingang Ying,Daisuke Endo,Zhiren Wu,Takehiko Koji.High expression of trimethylated histone H3 at lysine 27 predicts betterprognosis in non-small cell lung cancer[J]. International Journal of Oncology . 2013 (5)
  • 10Michael B. Scher,Michael B. Elbaum,Yakov Mogilevkin,David W. Hilbert,Jack H. Mydlo,A. Ami Sidi,Martin E. Adelson,Eli Mordechai,Jason P. Trama.Detecting DNA Methylation of the BCL2 , CDKN2A and NID2 Genes in Urine Using a Nested Methylation Specific Polymerase Chain Reaction Assay to Predict Bladder Cancer[J]. The Journal of Urology . 2012 (6)

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部